Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Spyre Therapeutics (SYRE) Gross Profit: 2015-2023

Historic Gross Profit for Spyre Therapeutics (SYRE) over the last 7 years, with Dec 2023 value amounting to $886,000.

  • Spyre Therapeutics' Gross Profit rose 10.08% to $688,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $1.2 million, marking a year-over-year decrease of 93.03%. This contributed to the annual value of $886,000 for FY2023, which is 61.96% down from last year.
  • Latest data reveals that Spyre Therapeutics reported Gross Profit of $886,000 as of FY2023, which was down 61.96% from $2.3 million recorded in FY2022.
  • Spyre Therapeutics' Gross Profit's 5-year high stood at $18.7 million during FY2021, with a 5-year trough of $886,000 in FY2023.
  • Moreover, its 3-year median value for Gross Profit was $2.3 million (2022), whereas its average is $7.3 million.
  • Data for Spyre Therapeutics' Gross Profit shows a maximum YoY plummeted of 87.57% (in 2022) over the last 5 years.
  • Spyre Therapeutics' Gross Profit (Yearly) stood at $18.7 million in 2021, then crashed by 87.57% to $2.3 million in 2022, then crashed by 61.96% to $886,000 in 2023.